Mad Honey is categorised at IMHSI based on grayanotoxin (GTX) content, and the institute is developing standardised label doses to ensure safe consumption. No such internationally recognised standard currently exists — this research programme is designed to produce it.
In parallel, each honey sample is analysed for a full range of chemical and bioactive properties, including antioxidant activity, antimicrobial potential, and immune-modulating effects. This multi-parameter approach ensures that standardisation covers both safety and quality — not only the absence of harm, but the presence of documented beneficial properties that can be substantiated in regulated markets.
IMHSI is developing a tiered classification system for Mad Honey based on total grayanotoxin concentration (primarily GTX-I and GTX-III). The system will define distinct potency categories with corresponding dosage guidance — allowing producers, retailers, and consumers to understand what they are working with in quantified, reproducible terms rather than anecdotal or regional convention.
Working from the GTX classification framework and the dose-response data generated by the Rat Toxicity Study, IMHSI is developing label dose recommendations. These will specify the maximum serving size (in grams) at each potency tier that keeps GTX exposure below established safety thresholds. Label dose recommendations will be submitted to relevant food safety authorities for regulatory review.
Each sample is screened for antioxidant capacity (DPPH and FRAP assays), antimicrobial activity against relevant pathogen panels, and preliminary immune-modulating markers. This data supports the development of scientifically substantiated claims for regulated export markets and provides a counterpoint to the anecdotal health claims that currently circulate around Mad Honey without evidence.
Defined dosage thresholds give consumers and healthcare providers the information needed to avoid accidental intoxication — which currently occurs due to the absence of any standardised guidance.
IMHSI’s standards are designed to align with Codex Alimentarius and EFSA frameworks, enabling legitimate export of authenticated Mad Honey into regulated markets where it currently cannot be sold.
A documented quality standard protects authentic producers from being undercut by adulterated or misrepresented products. Standards create a defensible market position for genuine Himalayan cliff honey.
IMHSI’s standardisation work is designed explicitly to create the regulatory submission package needed to get Mad Honey formally recognised within international food safety frameworks.
For research collaboration or regulatory enquiries, contact info@imhsinstitute.org.
This programme builds directly on our Rat Toxicity Study and Field Sample Collection data.
For general enquiries, visit our Contact page.